Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Cureus
|
June 24, 2024
X-linked Inhibitor of Apoptosis (XIAP) Deficiency Complicated by Hemophagocytic Lymphohistiocytosis on Immunotherapy Leading to Acute Respiratory Distress Syndrome and Multiorgan Failure Secondary to Opportunistic Infections
David Kim, Stephanie Liu, Eli Zolotov, et al.
Cureus
|
June 26, 2024
Dual Cardiac Arrests Leading to Hypercoagulability and Extensive Upper Extremity Deep Vein Thrombosis: A Hematological Case Report
Eli Zolotov, Neria Bitton, Anat Sigal, et al.
Cureus
|
February 26, 2024
Unusual Presentation of a Hepatic Neuroendocrine Tumor With Elevated CEA and CA 19-9: A Case Report
Eli Zolotov, Anat Sigal, Sara Hazaveh, et al.
Kidney & Blood Pressure Research
|
January 20, 2022
Can Renal Parameters Predict the Mortality of Hospitalized COVID-19 Patients?
Eli Zolotov, Anat Sigal, Martin Havrda, et al.
Kidney & Blood Pressure Research
|
May 11, 2023
Unveiling the Unexpected: Why Doctors Should Look beyond the Lungs when Predicting COVID-19 Mortality
Eli Zolotov, Anat Sigal, Martin Havrda, et al.
European Journal of Haematology
|
December 5, 2024
Venetoclax in the Treatment of Multiple Myeloma: A Retrospective Analysis of 79 Patients
Eli Zolotov, Vanisha Patel, Yedidyah Weiss, et al.
Cureus
|
June 24, 2024
Pneumatosis Intestinalis Following Surgical Gastrostomy Tube Placement in a Patient With Glottic Squamous Cell Carcinoma: A Case Report
Eli Zolotov, Caden Quintanilla, Noreen Ahmed, et al.
Leukemia & Lymphoma
|
July 31, 2024
Post-ASCT consolidation with elotuzumab, lenalidomide, and dexamethasone or elotuzumab, pomalidomide, and dexamethasone in high-risk and ultra-high-risk multiple myeloma: a retrospective single-center study
Eli Zolotov, Maciej Kabat, Harsh Parmar, et al.
Haematologica
|
April 3, 2025
A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma
Noa Biran, Eli Zolotov, David Vesole, et al.
Blood Cancer Journal
|
March 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium
Andrew J Portuguese, James A Davis, Shahzad Raza, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Cureus
|
June 24, 2024
X-linked Inhibitor of Apoptosis (XIAP) Deficiency Complicated by Hemophagocytic Lymphohistiocytosis on Immunotherapy Leading to Acute Respiratory Distress Syndrome and Multiorgan Failure Secondary to Opportunistic Infections
David Kim, Stephanie Liu, Eli Zolotov, et al.
Cureus
|
June 26, 2024
Dual Cardiac Arrests Leading to Hypercoagulability and Extensive Upper Extremity Deep Vein Thrombosis: A Hematological Case Report
Eli Zolotov, Neria Bitton, Anat Sigal, et al.
Cureus
|
February 26, 2024
Unusual Presentation of a Hepatic Neuroendocrine Tumor With Elevated CEA and CA 19-9: A Case Report
Eli Zolotov, Anat Sigal, Sara Hazaveh, et al.
Kidney & Blood Pressure Research
|
January 20, 2022
Can Renal Parameters Predict the Mortality of Hospitalized COVID-19 Patients?
Eli Zolotov, Anat Sigal, Martin Havrda, et al.
Kidney & Blood Pressure Research
|
May 11, 2023
Unveiling the Unexpected: Why Doctors Should Look beyond the Lungs when Predicting COVID-19 Mortality
Eli Zolotov, Anat Sigal, Martin Havrda, et al.
European Journal of Haematology
|
December 5, 2024
Venetoclax in the Treatment of Multiple Myeloma: A Retrospective Analysis of 79 Patients
Eli Zolotov, Vanisha Patel, Yedidyah Weiss, et al.
Cureus
|
June 24, 2024
Pneumatosis Intestinalis Following Surgical Gastrostomy Tube Placement in a Patient With Glottic Squamous Cell Carcinoma: A Case Report
Eli Zolotov, Caden Quintanilla, Noreen Ahmed, et al.
Leukemia & Lymphoma
|
July 31, 2024
Post-ASCT consolidation with elotuzumab, lenalidomide, and dexamethasone or elotuzumab, pomalidomide, and dexamethasone in high-risk and ultra-high-risk multiple myeloma: a retrospective single-center study
Eli Zolotov, Maciej Kabat, Harsh Parmar, et al.
Haematologica
|
April 3, 2025
A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma
Noa Biran, Eli Zolotov, David Vesole, et al.
Blood Cancer Journal
|
March 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium
Andrew J Portuguese, James A Davis, Shahzad Raza, et al.
Page
of 2